3 Axis Advisors collected data between 2019 and 2021 and identified significant disparities in reimbursement between pharmacies in the study and all pharmacy providers based on reimbursements reported to the Oregon Medicaid program as reflected in the State Drug Utilization Database. The report also discovered reimbursement discrepencies in other states, like Colorado.
top of page
Report details how prescription drug middleman profit at the expense of patients by inflating drug costs and squeezing Main Street...
There are many reasons I became a pharmacist, but a major reason was because I wanted to find ways to help and support the people in my...
The cost of prescription drugs in the U.S. isn’t like the tabs for other products. The price for a single medicine can range by...
bottom of page
Comments